Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)

NCT04127916 · clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center